Robeco Institutional Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25M | Sell |
|
|||||
|
2025
Q1 | $71.3M | Sell |
|
|||||
|
2024
Q4 | $92.1M | Buy |
|
|||||
|
2024
Q3 | $135M | Buy |
|
|||||
|
2024
Q2 | $133M | Buy |
|
|||||
|
2024
Q1 | $112M | Sell |
|
|||||
|
2023
Q4 | $106M | Buy |
|
|||||
|
2023
Q3 | $95.1M | Sell |
|
|||||
|
2023
Q2 | $88.3M | Sell |
|
|||||
|
2023
Q1 | $101M | Buy |
|
|||||
|
2022
Q4 | $88.8M | Buy |
|
|||||
|
2022
Q3 | $71.3M | Buy |
|
|||||
|
2022
Q2 | $48.9M | Buy |
|
|||||
|
2022
Q1 | $47.3M | Buy |
|
|||||
|
2021
Q4 | $31.9M | Sell |
|
|||||
|
2021
Q3 | $35.5M | Buy |
|
|||||
|
2021
Q2 | $20.8M | Sell |
|
|||||
|
2021
Q1 | $53.3M | Sell |
|
|||||
|
2020
Q4 | $76.6M | Sell |
|
|||||
|
2020
Q3 | $97.5M | Buy |
|
|||||
|
2020
Q2 | $96.7M | Buy |
|
|||||
|
2020
Q1 | $17.3M | Buy |
|
|||||
|
2019
Q4 | $4.91M | Sell |
|
|||||
|
2019
Q3 | $5.05M | Sell |
|
|||||
|
2019
Q2 | $6.06M | Sell |
|
|||||
|
2019
Q1 | $8.75M | Buy |
|
|||||
|
2018
Q4 | $4.98M | Buy |
|
|||||
|
2018
Q3 | $2.25M | Buy |
|
|||||
|
2018
Q2 | $1.57M | Sell |
|
|||||
|
2018
Q1 | $1.81M | Buy |
|
|||||
|
2017
Q4 | $391K | Hold |
|
|||||
|
2017
Q3 | $463K | Buy |
|
|||||
|
2017
Q2 | $504K | Hold |
|
|||||
|
2017
Q1 | $398K | Sell |
|
|||||
|
2016
Q4 | $396K | Sell |
|
|||||
|
2016
Q3 | $1.36M | Sell |
|
|||||
|
2016
Q2 | $1.93M | Hold |
|
|||||
|
2016
Q1 | $2M | Sell |
|
|||||
|
2015
Q4 | $3.69M | Buy |
|
|||||
|
2015
Q3 | $2.29M | Buy |
|
|||||
|
2015
Q2 | $1.55M | Buy |
|
|||||
|
2015
Q1 | $1.08M | Buy |
|
|||||
|
2014
Q4 | $846K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $358K | Buy |
|
|||||
|
2014
Q1 | $185K | Buy |
|
|||||
|
2013
Q4 | $125K | Hold |
|
|||||
|
2013
Q3 | $142K | Hold |
|
|||||
|
2013
Q2 | $102K | Buy |
|